Risultati di ricerca
28 feb 2024 · Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's marketed...
- Financials
Get the detailed quarterly/annual income statement for Vanda...
- Chart
Interactive Chart for Vanda Pharmaceuticals Inc. (VNDA),...
- News
The latest news and headlines from Yahoo News. Get breaking...
- Options
View the basic VNDA option chain and compare options of...
- Sustainability
See Vanda Pharmaceuticals Inc. (VNDA) Environment, Social...
- Holders
Find out the direct holders, institutional holders and...
- Financials
17 apr 2024 · Vanda's (VNDA) board of directors unanimously rejects takeover proposals from Future Pak to acquire all outstanding shares of Vanda. Shares rise on the news. Get the latest Vanda...
7 feb 2024 · About Vanda Pharmaceuticals Inc. Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.
3 giorni fa · 0.29%. $331.19B. VNDA | Complete Vanda Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
5 giorni fa · Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results. Revenues for Q1 2024 were $47.5 million, an increase of 5% compared to Q4 2023 Cash increase of $5.9 million in Q1 2024 to $394.1 million Fanapt® approved for the acute treatment of bipolar I disorder... 11 days ago - PRNewsWire.
8 nov 2023 · Vanda provides update on pipeline advancements and regulatory plans. WASHINGTON, Nov. 8, 2023 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced financial and operational results for the third quarter ended September 30, 2023.
3 apr 2024 · Fifteen years after gaining its first FDA approval for Fanapt (iloperidone) to treat schizophrenia, Vanda Pharmaceuticals has scored again with the same antipsychotic drug. The FDA has signed...
